Prostatis Group Portfolio holdings
Top Buys
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$7.32M |
| 2 |
First Trust Long/Short Equity ETF
FTLS
|
+$3.62M |
| 3 |
FT Vest US Equity Max Buffer ETF March
MARM
|
+$3.13M |
| 4 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$2.73M |
| 5 |
iShares MSCI India ETF
INDA
|
+$2.61M |
Top Sells
Sector Composition
| 1 | Technology | 4.37% |
| 2 | Consumer Discretionary | 2.45% |
| 3 | Industrials | 2.11% |
| 4 | Financials | 1.77% |
| 5 | Healthcare | 1.53% |
Similar funds
Prostatis Group's Q2 2024 Portfolio in Review
As of Q2 2024, Prostatis Group held 159 positions worth $285M, up 8.1% from $264M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Prostatis Group deployed $15.2M of net new capital in Q2 2024, opening 24 new positions and adding to 61 existing holdings. Its largest new stake was First Trust Long/Short Equity ETF: 59,184 shares worth $3.74M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 3.3% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $3.47M trimmed.
- Prostatis Group's largest Q2 2024 buy was First Trust Long/Short Equity ETF: 59,184 shares worth $3.74M.
- Prostatis Group added most to State Street Financial Select Sector SPDR ETF in Q2 2024, an estimated $7.32M increase.
- Prostatis Group's biggest Q2 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $3.47M.
- Prostatis Group fully exited Invesco S&P 500 High Beta ETF in Q2 2024, selling an estimated $4.54M.
- Prostatis Group's ten largest holdings make up 39% of its $285M portfolio in Q2 2024.
- Prostatis Group opened 24 new positions and closed 12 in Q2 2024.
- Prostatis Group's portfolio value rose 8.1% quarter-over-quarter to $285M.
Based on Prostatis Group's 13F filing for Q2 2024, filed 21 Mar 2025.